4.7 Article

Design, synthesis and neurite outgrowth activity of novel ganglioside GM1 derivatives by remodeling of the fatty acid moiety

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The Key Role of GM1 Ganglioside in Parkinson's Disease

Suman Chowdhury et al.

Summary: In this review, we summarize our findings of a systemic deficiency of ganglioside GM1 in Parkinson's disease (PD) tissues. The deficiency is observed in various neuronal and non-neuronal tissues, which suggests a potential underlying mechanism for loss of neuronal viability and normal functioning. We discuss the causes of these deficiencies and propose GM1 replacement as a potential therapy for PD based on strong evidence from animal studies and clinical trials.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

GM1 Is Cytoprotective in GPR37-Expressing Cells and Downregulates Signaling

Ellen Hertz et al.

Summary: The study revealed that GPR37 and GM1 can form a complex in cells, and exogenous GM1 can rescue cells from neurotoxin-induced toxicity. The treatment did not alter transcription levels of GPR37 or the enzyme responsible for GM1 production, but inhibited cAMP-dependent signaling from GPR37.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Protective Effect of GM1 Attenuates Hippocampus and Cortex Apoptosis After Ketamine Exposure in Neonatal Rat via PI3K/AKT/GSK3β Pathway

Zhiheng Zhang et al.

Summary: GM1 alleviates ketamine-induced apoptosis in rats by regulating the PI3K/AKT/GSK3 beta pathway.

MOLECULAR NEUROBIOLOGY (2021)

Article Biotechnology & Applied Microbiology

Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse

Yutaka Itokazu et al.

Summary: Supplementation with GM1 gangliosides can reduce levels of α-synuclein, enhance expression of tyrosine hydroxylase, and restore functional neurons.

MOLECULAR THERAPY (2021)

Review Genetics & Heredity

GM1 Gangliosidosis-A Mini-Review

Elena-Raluca Nicoli et al.

Summary: GM1 gangliosidosis is a progressive lysosomal storage disorder caused by mutations in the GLB1 gene, leading to accumulation of glycosphingolipids in neuronal tissue. The disease is classified into three forms based on age of onset, with severe neurocognitive decline being a common feature. Several gene therapy trials are currently recruiting patients for potential treatment options.

FRONTIERS IN GENETICS (2021)

Article Biochemistry & Molecular Biology

Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats

Fahime Zavvari et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2020)

Article Chemistry, Multidisciplinary

One-Pot Synthesis of DOX@Covalent Organic Framework with Enhanced Chemotherapeutic Efficacy

Sainan Liu et al.

CHEMISTRY-A EUROPEAN JOURNAL (2019)

Article Chemistry, Organic

Streamlined chemoenzymatic total synthesis of prioritized ganglioside cancer antigens

Hai Yu et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2018)

Article Multidisciplinary Sciences

Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism

Heather A. Ferris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells

Walaa Eid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Neurosciences

GM1 Ganglioside: Past Studies and Future Potential

Massimo Aureli et al.

MOLECULAR NEUROBIOLOGY (2016)

Article Biotechnology & Applied Microbiology

Comprehensive characterization of sphingolipid ceramide N-deacylase for the synthesis and fatty acid remodeling of glycosphingolipids

Yun-Bin Han et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)

Review Biochemistry & Molecular Biology

The multi-tasked life of GM1 ganglioside, a true factotum of nature

Robert W. Ledeen et al.

TRENDS IN BIOCHEMICAL SCIENCES (2015)

Article Neurosciences

Exogenous gangliosides increase the release of brain-derived neurotrophic factor

Seung T. Lim et al.

NEUROPHARMACOLOGY (2011)

Review Biochemistry & Molecular Biology

Very long chain sphingolipids: Tissue expression, function and synthesis

Roger Sandhoff

FEBS LETTERS (2010)

Review Neurosciences

Lipid rafts, cholesterol, and the brain

Zeljka Korade et al.

NEUROPHARMACOLOGY (2008)

Article Cell Biology

SREBP in signal transduction: cholesterol metabolism and beyond

Maria T. Bengoechea-Alonso et al.

CURRENT OPINION IN CELL BIOLOGY (2007)

Review Biochemistry & Molecular Biology

White matter rafting - Membrane microdomains in myelin

Lillian S. DeBruin et al.

NEUROCHEMICAL RESEARCH (2007)

Article Biochemistry & Molecular Biology

C18:3-GM1a induces apoptosis in Neuro2a cells:: enzymatic remodeling of fatty acyl chains of glycosphingolipids

T Nakagawa et al.

JOURNAL OF LIPID RESEARCH (2005)

Article Nutrition & Dietetics

Human and bovine milk ganliosides in their fatty acid composition

L Bode et al.

JOURNAL OF NUTRITION (2004)

Review Biochemistry & Molecular Biology

Got RIP? Presenilin-dependent intramembrane proteolysis in growth factor receptor signaling

N Landman et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2004)

Article Neurosciences

GM1 enhances dopaminergic markers in the brain of aged rats

VM Goettl et al.

EXPERIMENTAL NEUROLOGY (2003)

Review Biochemistry & Molecular Biology

Ganglioside/glycosphingolipid turnover: New concepts

G Tettamanti

GLYCOCONJUGATE JOURNAL (2003)

Article Biochemistry & Molecular Biology

Gangliosides activate Trk receptors by inducing the release of neurotrophins

SJ Rabin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Biochemistry & Molecular Biology

Cholesterol metabolism in the brain

JM Dietschy et al.

CURRENT OPINION IN LIPIDOLOGY (2001)